Literature DB >> 14729591

Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA.

Pavel Vodicka1, Rajiv Kumar, Rudolf Stetina, Somali Sanyal, Pavel Soucek, Vincent Haufroid, Maria Dusinska, Miroslava Kuricova, Maria Zamecnikova, Ludovit Musak, Jana Buchancova, Hannu Norppa, Ari Hirvonen, Ludmila Vodickova, Alessio Naccarati, Zora Matousu, Kari Hemminki.   

Abstract

We analysed the associations between genetic polymorphisms in genes coding for DNA repair enzymes XPD (exon 23 A --> C, K751Q), XPG (exon 15 G --> C, D1104H), XPC (exon 15 A --> C, K939Q), XRCC1 (exon 10 G --> A, R399Q) and XRCC3 (exon 7 C --> T, T241 M) and the levels of chromosomal aberrations (CAs) and single-strand breaks (SSBs) in peripheral lymphocytes in a central European population. We also measured the irradiation-specific DNA repair rates and the repair rates of 8-oxoguanines in these individuals. An elevated frequency of CAs was observed in individuals with the XPD exon 23 A allele (AA and AC) genotypes (F = 3.6, P = 0.028, ANOVA). In multifactorial analysis of variance, the XPD exon 23 polymorphism appeared as a major factor influencing CAs (F = 4.2, P = 0.017). SSBs in DNA, on the other hand, were modulated by XPD (F = 4.3, P = 0.023), XPG (F = 4.3, P = 0.024) and XRCC1 genotypes (F = 3.0, P = 0.064). Irradiation-specific DNA repair rates (reflecting mainly base excision repair activity) were affected by XRCC1 (F = 5.9, P = 0.010) and XPC polymorphisms (F = 4.2, P = 0.046, MANOVA). Our results from this study suggest that markers of genotoxicity are associated with polymorphisms in genes encoding DNA repair enzymes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14729591     DOI: 10.1093/carcin/bgh064

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  47 in total

1.  DNA repair capacity, DNA-strand break repair gene polymorphisms, and the incidence of hepatocellular carcinoma in southwestern Guangxi of China.

Authors:  Xiaoyun Zeng; Shun Liu; Hongping Yu; Long Ji; Longman Li; Jinmei Huang; Hua Bai; Xiaoqiang Qiu
Journal:  DNA Cell Biol       Date:  2012-06-12       Impact factor: 3.311

2.  Nucleotide excision repair polymorphisms and survival outcome for patients with metastatic breast cancer.

Authors:  Mary A Bewick; Robert M Lafrenie; Michael S C Conlon
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-28       Impact factor: 4.553

3.  Oligogenic combinations associated with breast cancer risk in women under 53 years of age.

Authors:  Christopher E Aston; David A Ralph; Dominique P Lalo; Sharmila Manjeshwar; Bobby A Gramling; Daniele C DeFreese; Amy D West; Dannielle E Branam; Linda F Thompson; Melissa A Craft; Debra S Mitchell; Craig D Shimasaki; John J Mulvihill; Eldon R Jupe
Journal:  Hum Genet       Date:  2004-12-21       Impact factor: 4.132

4.  The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk.

Authors:  Li Jiao; Manal M Hassan; Melissa L Bondy; James L Abbruzzese; Douglas B Evans; Donghui Li
Journal:  Cancer Lett       Date:  2006-02-03       Impact factor: 8.679

5.  Modulation of DNA damage/DNA repair capacity by XPC polymorphisms.

Authors:  Yimin Zhu; Hushan Yang; Qin Chen; Jie Lin; H Barton Grossman; Colin P Dinney; Xifeng Wu; Jian Gu
Journal:  DNA Repair (Amst)       Date:  2007-10-17

6.  Hodgkin lymphoma risk: role of genetic polymorphisms and gene-gene interactions in DNA repair pathways.

Authors:  Claudia M Monroy; Andrea C Cortes; Mirtha Lopez; Elizabeth Rourke; Carol J Etzel; Anas Younes; Sara S Strom; Randa El-Zein
Journal:  Mol Carcinog       Date:  2011-03-03       Impact factor: 4.784

7.  Sensitivity to cisplatin-induced mutations and elevated chromosomal aberrations in lymphocytes from sickle cell disease patients.

Authors:  Polyanna Miranda Alves; Paulo Roberto Juliano Martins; Francisca da Luz Dias; Rommel Mario Rodríguez Burbano; Maria de Lourdes Pires Bianchi; Lusânia Maria Greggi Antunes
Journal:  Clin Exp Med       Date:  2008-04-03       Impact factor: 3.984

8.  Evidence of increased chromosomal abnormalities in French Polynesian thyroid cancer patients.

Authors:  D Violot; R M'Kacher; E Adjadj; J Dossou; F de Vathaire; C Parmentier
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-09-23       Impact factor: 9.236

9.  XRCC1 polymorphisms and breast cancer risk from the New York Site of the Breast Cancer Family Registry: A family-based case-control study.

Authors:  Jennifer Zipprich; Mary Beth Terry; Paul Brandt-Rauf; Greg A Freyer; Yuyan Liao; Meenakshi Agrawal; Irina Gurvich; Ruby Senie; Regina M Santella
Journal:  J Carcinog       Date:  2010-04-16

10.  Do GST polymorphisms modulate the frequency of chromosomal aberrations in healthy subjects?

Authors:  Pavel Vodicka; Alessio Naccarati; Ludmila Vodickova; Veronika Polakova; Maria Dusinska; Ludovit Musak; Erika Halasova; Simona Susova; Pavel Soucek; Kari Hemminki
Journal:  Environ Health Perspect       Date:  2009-09       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.